Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease - 28/08/11
Doi : 10.1016/S0002-9149(03)00161-9
Wright B Lauten, BS a, Qamar A Khan, MD a, Sanjay Rajagopalan, MD b, Stamatios Lerakis, MD a, Syed T Rahman, MD a, Sampath Parthasarathy, PhD a, Bobby V Khan, MD, PhD a, ⁎ 
a Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
b University of Michigan, Division of Cardiology, Ann Arbor, Michigan, USADr. B. Khan was supported by the Emory Medical Care Foundation, Atlanta, Georgia, and Dr. Parthasarathy was supported by grant R01-HL34453 from the National Institutes of Health/National Heart, Lung, and Blood Institute, Bethesda, Maryland.
*Dr. B. Khan’s address is: Emory University School of Medicine, Division of Cardiology, 69 Jesse Hill Drive SE, C233, Atlanta, Georgia , USA30303.
© 2003
Excerpta Medica Inc. Tous droits réservés.
Vol 91 - N° 9
P. 1116-1119 - mai 2003 Retour au numéro
Article précédent
- Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition With Beta In-Stent Trial
- Kazuyuki Shirai, Alexandra J. Lansky, Gary S. Mintz, Costantino O. Costantini, Ecatarina Cristea, Martin Fahy, Lynn Vandertie, Alan Yeung, Albert E. Raizner, Ron Waksman, Martin B. Leon
- Association between inflammatory markers, hemostatic, and lipid factors in postinfarction patients
- Tareq S Harb, Wojciech Zareba, Arthur J Moss, Paul M Ridker, Nader Rifai, Victor J Marder, Luc Miller-Watelet, THROMBO Investigators
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?